Odesivimab

Records for this ingredient, by country (identity only).

ATC — · 1 markets · 2 records

Odesivimab 1 markets · 2 records Forms
Filters
MarketUS 2
Kind

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

  • 483.3 mg/14.5 mLinjection CombinationAtoltivimab 483.3 mg/14.5 mL + Maftivimab 483.3 mg/14.5 mL + Odesivimab 483.3 mg/14.5 mLInmazeb
  • 241.7 mg/14.5 mLinjection CombinationAtoltivimab 241.7 mg/14.5 mL + Maftivimab 241.7 mg/14.5 mL + Odesivimab 241.7 mg/14.5 mLInmazeb
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.